Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar?/? C57B...
Enregistré dans:
Auteurs principaux: | , , , |
---|---|
Format: | Article |
Langue: | anglais |
Publié: |
Philipps-Universität Marburg
2023
|
Sujets: | |
Accès en ligne: | Texte intégral en PDF |
Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
No abstracts were found for this record.